Austin Westerling

Partner at Granite Point Capital

📍 Greater Boston, United States🔄 Updated September 2026💼 27 investments📅 22 years investing🗓 Last invested Jan 2022
VC🌍 United States20+ investments
27
Total investments
4
Early stage
7
Mid stage
3
Late stage
22y
Years active

Portfolio

19 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Jan 2022
Route is the leader in the post-purchase experience. From delivery to re-discovery, Route protects brands and their customers with licensed shipping insurance, fast issue resolution, package tracking, returns and exchanges, and remarketing. Route helps brands control for the unexpected and transform even negative experiences into opportunities to drive loyalty. Since launching in 2019, Route has built an ecommerce network of 13,000 brands and 3+ million active app users, and customers have chosen to protect nearly 150 million orders. Route seamlessly integrates with leading ecommerce platforms, including Shopify, Salesforce Commerce Cloud, Magento, BigCommerce, and WooCommerce, and also provides custom API integrations for enterprise merchants.
Investor
Nov 2020
We’re excited to announce that Divvy has a new name: BILL Spend & Expense. Everything you love about Divvy is staying the same—from setting budgets to tracking spend and getting access to the credit your business needs to grow¹. And now, you’ll have even more opportunities to simplify your financial operations. More efficiency. More control. More visibility. All on one platform. Follow our BILL company page to learn more. ¹Credit lines are not guaranteed and will be determined upon application approval.
Investor
Oct 2018
Receptor Life Sciences combines proven drug delivery technologies, compelling therapeutic candidates, and traditional drug development research practices to pursue a robust range of prescription drug treatments for CNS indications. The delivery technologies, used in both oral and inhaled FDA-approved prescription drug products, represent a validated, strategic approach to overcoming traditional challenges of cannabinoid medicine. Receptor’s patented product candidates hold the potential to provide prescription treatments for a range of unmet medical needs, including anxiety and agitation in autism. More information is at www.ReceptorLife.com.
Investor
May 2018
Headquartered in New York City, Acreage is a multi-state operator of cannabis ‎cultivation and retailing facilities in the U.S., including the company’s national retail store ‎brand, The Botanist. Acreage’s wide range of national and regionally available cannabis products include the award-winning Botanist brand, the highly recognizable Tweed brand, the Prime medical brand in Pennsylvania, the Innocent edibles brand in Illinois and others. Acreage also owns Universal Hemp, LLC, a hemp subsidiary dedicated to the distribution, marketing and sale of CBD products throughout the U.S. Since its founding in 2011, Acreage has focused on building and scaling operations to create a ‎seamless, consumer-focused, branded experience. More information is available at www.acreageholdings.com.
Board Member
Mar 2018
Teikametrics helps thousands of sellers and brand owners grow their businesses on Amazon and Walmart.com through the combination of data, AI-powered technology, and marketplace expertise. Teikametrics Flywheel, the first Marketplace Optimization Platform, connects and optimizes critical ecommerce business operations including advertising, inventory, and market intelligence - all in one place. Teikametrics’ unrivaled data access, scale, and AI technology optimizes over $7B in Amazon and Walmart.com sales annually. Learn more at www.teikametrics.com Interested in joining Team Teika? Visit www.teikametrics.com/careers to see our open positions!
Investor
Mar 2018
Cerebral Therapeutics, Inc. is a clinical-stage pharmaceutical company dedicated to improving the lives of patients living with severe refractory epilepsy and other uncontrolled neurological diseases. Founded by experts in the fields of neurology, neurosurgery, and drug delivery, the Company is pioneering the development of drug-device combination therapies that enable precise targeted delivery to the central nervous system.
Investor
Jan 2018
Pioneering tRNA therapeutics to modulate mRNA function and cure a broad range of genetic diseases.
Investor
Nov 2017
Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), is a leading global lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is leading as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. Tilray’s mission is to be a leading premium lifestyle company with a house of brands and innovative products that inspire joy, wellness and create memorable experiences. Tilray’s unprecedented platform supports over 40 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.
Investor
Oct 2017
Papa & Barkley™ is the leading California cannabis wellness brand, #1 in topicals and tinctures. Basing its production in Humboldt County, California, Papa & Barkley partners with second- and third-generation farmers to source cannabis grown using organic and regenerative farming principles. The company uses proprietary solventless, completely chemical-free, whole plant infusion processes to craft its products, ensuring they are clean, safe, high-quality, and contain the plant's natural nutrient profile to maximize efficacy. Papa & Barkley™ offers a range of THC-rich and CBD-rich Whole Plant Full Spectrum™ formulas to provide relief for a variety of individuals' needs. Papa & Barkley was inspired by a son's mission to ease his father's debilitating back pain. Today the company continues to care for loved ones by unlocking the potential of the plant to improve lives.
mid stageManufacturing
Investor
Sep 2017
About DOTS DOTS (Detection On the Spot) has a mission to make people’s lives better through a disruptive diagnostics platform that gives them information to make better decisions. We are developing a food allergen detector for consumers to test food prior to consumption. Privately held, VC funded, DOTS is a consumer products company with an emphasis on teamwork and innovation. Based in Natick, Massachusetts.
Investor
Aug 2017
THE PARENT COMPANY brings together global icon and entrepreneur Shawn “JAY-Z” Carter, entertainment powerhouse ROC NATION, California’s most trusted cannabis brand and leading direct-to-consumer platform CALIVA, and leading cannabis and hemp manufacturer and house of brands LEFT COAST VENTURES, to form one of the most dynamic and exciting companies in the cannabis industry. We are on a mission to create the most impactful cannabis company in the world, by combining best-in-class operations with leading voices in popular culture and social impact.
early stageManufacturing
Investor
Aug 2017
Founded in 2010 in Seattle by three visionary entrepreneurs with decades of experience in investment banking and venture capital, we represent a group of investors from around the world seeking to end cannabis prohibition and the social harms it causes. Through a combination of acquisitions, investments and incubation, we are focused on building a portfolio of global brands that will lead, legitimize and define the future of cannabis. We have three fundamental beliefs: 1. Cannabis is a mainstream product consumed by mainstream people; 2. The end of cannabis prohibition is inevitable; and 3. Brands will determine the future of the cannabis industry. We are set apart by the depth of hands-on management and investment experience of our team, which includes Ivy League MBAs, PhD research scientists, marketing professionals and operators from world-leading brands, and even former federal law enforcement professionals. In an industry stigmatized by negative perceptions and substandard business practices, we are elevating consumer expectations through consistent quality and service. When prohibition ends, we intend to hold the most enviable position in the market and to generate enormous returns – both financial and social.
Investor
Aug 2017
Leafly is the world’s most trusted destination to discover cannabis products and order them from legal, licensed retailers. More than 100 million people visit Leafly each year to learn more about cannabis and order online with local businesses.
Investor
Jun 2016
Tomorrow - Are you ready? Our mission is to help protect families like yours by making expensive legal documents free for everyone. Life is the ultimate reward. Be prepared for the risks. Download the Tomorrow app now on iOS or Android. http://tmro.com
Investor
Jun 2016
Ethos makes getting life insurance instant and easy. Our approach blends technology and industry expertise, and the human touch to deliver an incredible life insurance experience. Ethos has raised over $400 million of capital from Sequoia, Accel, Google Ventures, Goldman Sachs, Softbank and more. We are one of the largest U.S. life insurance issuers. We continue to scale quickly and are looking for passionate Ethosaurs to protect the next million families.
early stageInsurance
Show all 19 investments ↓
Experience · 29 entries
All (29)
Investments (27)
Board (7)
2022
Investor
Jan 2022
Route is the leader in the post-purchase experience. From delivery to re-discovery, Route protects brands and their customers with licensed shipping insurance, fast issue resolution, package tracking, returns and exchanges, and remarketing. Route helps brands control for the unexpected and transform even negative experiences into opportunities to drive loyalty. Since launching in 2019, Route has built an ecommerce network of 13,000 brands and 3+ million active app users, and customers have chosen to protect nearly 150 million orders. Route seamlessly integrates with leading ecommerce platforms, including Shopify, Salesforce Commerce Cloud, Magento, BigCommerce, and WooCommerce, and also provides custom API integrations for enterprise merchants.
2020
Investor
Nov 2020
We’re excited to announce that Divvy has a new name: BILL Spend & Expense. Everything you love about Divvy is staying the same—from setting budgets to tracking spend and getting access to the credit your business needs to grow¹. And now, you’ll have even more opportunities to simplify your financial operations. More efficiency. More control. More visibility. All on one platform. Follow our BILL company page to learn more. ¹Credit lines are not guaranteed and will be determined upon application approval.
2018
Receptor Life Sciences
Investor
Oct 2018
Investor
Oct 2018
Receptor Life Sciences combines proven drug delivery technologies, compelling therapeutic candidates, and traditional drug development research practices to pursue a robust range of prescription drug treatments for CNS indications. The delivery technologies, used in both oral and inhaled FDA-approved prescription drug products, represent a validated, strategic approach to overcoming traditional challenges of cannabinoid medicine. Receptor’s patented product candidates hold the potential to provide prescription treatments for a range of unmet medical needs, including anxiety and agitation in autism. More information is at www.ReceptorLife.com.
Investor
May 2018
Headquartered in New York City, Acreage is a multi-state operator of cannabis ‎cultivation and retailing facilities in the U.S., including the company’s national retail store ‎brand, The Botanist. Acreage’s wide range of national and regionally available cannabis products include the award-winning Botanist brand, the highly recognizable Tweed brand, the Prime medical brand in Pennsylvania, the Innocent edibles brand in Illinois and others. Acreage also owns Universal Hemp, LLC, a hemp subsidiary dedicated to the distribution, marketing and sale of CBD products throughout the U.S. Since its founding in 2011, Acreage has focused on building and scaling operations to create a ‎seamless, consumer-focused, branded experience. More information is available at www.acreageholdings.com.
Show all 29 entries ↓
Investment activity
2004–2022 · 27 investments
2004120052200712008120093201022016220176201872020120221
Recent (last 2 years)Earlier